+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

  • ID: 5238726
  • Report
  • May 2022
  • Region: Global
  • 66 Pages
  • Koncept Analytics
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

FEATURED COMPANIES

  • Biomerieux SA
  • Catalent, Inc.
  • Evotec SE
  • Lonza Group AG
  • Recipharm AB
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global CDMO market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market. However, growth of the industry will be challenged by stringent government regulations. A few notable trends include increasing demand for highly potent API manufacturing services, growing demand for quality by design services, growth in oncology segment, growing demand for process development CDMO services and lengthy and costly drug development process..





In terms of services, the global API drug market accounted for the highest share of the market and is expected to grow in future owing to growing number of biologics APIs in pipeline stage and growing adoption of multiple of therapies. Whereas on the basis of product, Small molecule drugs held a major share of the market owing to the surge in the pharmaceutical R&D activities worldwide.

Scope of the report

  • The report provides a comprehensive analysis of the global CDMO industry
  • The major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The company profiles of leading players (Catalent, Inc., Recipharm AB, Evotec SE, Lonza Group AG, Biomerieux SA and Thermo Fisher Scientific Inc.) are also presented in detail

Key Target Audience

  • Contract Manufacturing Organization
  • Pharmaceutical Companies
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities
Frequently Asked Questions about the Global CDMO Market

What is the estimated value of the Global CDMO Market?

The Global CDMO Market was estimated to be valued at $172.7 Billion in 2022.

What is the growth rate of the Global CDMO Market?

The growth rate of the Global CDMO Market is 9.3%, with an estimated value of $246.6 Billion by 2026.

What is the forecasted size of the Global CDMO Market?

The Global CDMO Market is estimated to be worth $246.6 Billion by 2026.

Who are the key companies in the Global CDMO Market?

Key companies in the Global CDMO Market include Biomerieux SA, Catalent, Inc., Evotec SE, Lonza Group AG and Thermo Fisher Scientific Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomerieux SA
  • Catalent, Inc.
  • Evotec SE
  • Lonza Group AG
  • Recipharm AB

1. Introduction
1. CDMO
1.2 CDMO Services
1.3 Advantages of CDMO
2. Impact of COVID-19
2.1 Rise in Clinical Trials
3. Global CDMO Market Analysis
3.1 Global CDMO Market by Value
3.2 Global CDMO Market Forecast by Value
3.3 Global CDMO Market by Service
3.3.1 Global API/Bulk Drugs Market by Value
3.3.2 Global API/Bulk Drugs Market Forecast by Value
3.3.3 Global Drug Product Manufacturing Market by Value
3.3.4 Global Drug Product Manufacturing Market Forecast by Value
3.3.5 Global Packaging Market by Value
3.3.6 Global Packaging Market Forecast by Value
3.4 Global CDMO Market by Product
3.4.1 Global Biologics CDMO Market by Value
3.4.2 Global Biologics CDMO Market Forecast by Value
3.4.3 Global Small Molecule CDMO Market by Value
3.4.4 Global Small Molecule CDMO Market Forecast by Value
3.5 Global CDMO Market by Region
4. Regional CDMO Market Analysis
4.1 North America
4.1.1 North America CDMO Market by Value
4.1.2 North America CDMO Market Forecast by Value
4.2 Europe
4.2.1 Europe CDMO Market by Value
4.2.2 Europe CDMO Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific CDMO Market by Value
4.3.2 Asia Pacific CDMO Market Forecast by Value
4.4 Latin America
4.4.1 Latin America CDMO Market by Value
4.4.2 Latin America CDMO Market Forecast by Value
4.5 Middle East & Africa
4.5.1 Middle East & Africa CDMO Market by Value
4.5.2 Middle East & Africa CDMO Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Per Capita Disposable Income
5.1.2 Increasing Global Healthcare Expenditure
5.1.3 Rising Aging Population
5.1.4 Increasing R&D Spending
5.1.5 Growing Number of New Drugs
5.1.6 Rise in Investments and Strategic Collaborations
5.1.7 Growing Demand for Pharmaceutical Products
5.2 Key Trends & Developments
5.2.1 Increasing Demand for Highly Potent API Manufacturing Services
5.2.2 Growing Demand for Quality by Design Services
5.2.3 Growth in Oncology Segment
5.2.4 Growing Demand for Process Development CDMO Services
5.2.5 Lengthy and Costly Drug Development Process
5.3 Challenges
5.3.1 Stringent Government Regulations
6. Company Profiles
6.1 Catalent, Inc.
6.1.1 Business Overview
6.2 Recipharm AB
6.2.1 Business Overview
6.3 Evotec SE
6.3.1 Business Overview
6.4 Lonza Group AG
6.4.1 Business Overview
6.5 Biomerieux SA
6.5.1 Business Overview
6.6 Thermo Fisher Scientific Inc.
6.6.1 Business Overview
List of Figures
  • CDMO Services
  • Number of Clinical Trials for COVID-19 Vaccines and Diagnostic Kits (2020)
  • Global CDMO Market by Value (2017-2021)
  • Global CDMO Market Forecast by Value (2022-2026)
  • Global CDMO Market by Service (2021)
  • Global API/Bulk Drugs Market by Value (2017-2021)
  • Global API/Bulk Drugs Market Forecast by Value (2022-2026)
  • Global Drug Product Manufacturing Market by Value (2017-2021)
  • Global Drug Product Manufacturing Market Forecast by Value (2022-2026)
  • Global Packaging Market by Value (2017-2021)
  • Global Packaging Market Forecast by Value (2022-2026)
  • Global CDMO Market by Product (2021)
  • Global Biologics CDMO Market by Value (2017-2021)
  • Global Biologics CDMO Market Forecast by Value (2022-2026)
  • Global Small Molecule CDMO Market by Value (2017-2021)
  • Global Small Molecule CDMO Market Forecast by Value (2022-2026)
  • Global CDMO Market by Region (2021)
  • North America CDMO Market by Value (2017-2021)
  • North America CDMO Market Forecast by Value (2022-2026)
  • Europe CDMO Market by Value (2017-2021)
  • Europe CDMO Market Forecast by Value (2022-2026)
  • Asia Pacific CDMO Market by Value (2017-2021)
  • Asia Pacific CDMO Market Forecast by Value (2022-2026)
  • Latin America CDMO Market by Value (2017-2021)
  • Latin America CDMO Market Forecast by Value (2022-2026)
  • Middle East & Africa CDMO Market by Value (2017-2021)
  • Middle East & Africa CDMO Market Forecast by Value (2022-2026)
  • Global GNI Per Capita (2015-2019)
  • Global Healthcare Expenditure Per Capita (2017-2021)
  • Global Aging Population (2017-2021)
  • Global Pharmaceutical R&D Expenditure (2022-2026)
  • FDA Approval of Chemical NMEs and Biologics (2015-2019)
Note: Product cover images may vary from those shown
  • Biomerieux SA
  • Catalent, Inc.
  • Evotec SE
  • Lonza Group AG
  • Recipharm AB
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown